“Tesamorelin reduces visceral fat in adults with HIV-associated lipodystrophy.”

01 · Answer

Supported with scope

Phase 3 trials and the product label support this outcome in the labeled population.

What kind of evidence this is

Randomized human outcomes. This answer uses a study that assigned people to groups by chance and measured a health outcome.

What this answer covers

Adults with HIV and excess abdominal fat meeting the trial and label criteria. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.

Question type

Body composition. What research measured about body fat, lean mass, or related body changes.